Hematopoietic stem cell transplantation for pediatric acute promyelocytic leukemia in Japan.
Shohei YamamotoMasanori YoshidaKazuko KudoDaiichiro HasegawaTakashi TagaMasamitsu YanadaTadakazu KondoYozo NakazawaTetsuya EtoMasami InoueKoji KatoYoshiko AtsutaHiroyuki IshidaPublished in: Pediatric blood & cancer (2020)
Even after relapsing, childhood APL can be cured with HSCT if CR is achieved. These findings demonstrate that achieving CR followed by HSCT is the preferred strategy for treating children with relapsed or refractory APL.